Nils W. Engel

3.6k total citations
14 papers, 247 citations indexed

About

Nils W. Engel is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Nils W. Engel has authored 14 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Nils W. Engel's work include CAR-T cell therapy research (7 papers), CRISPR and Genetic Engineering (3 papers) and Virus-based gene therapy research (2 papers). Nils W. Engel is often cited by papers focused on CAR-T cell therapy research (7 papers), CRISPR and Genetic Engineering (3 papers) and Virus-based gene therapy research (2 papers). Nils W. Engel collaborates with scholars based in Germany, United States and Canada. Nils W. Engel's co-authors include Carl H. June, Regina M. Young, Nils Wellhausen, Uğur Uslu, Ryan P. O’Connell, Donna Gonzales, Austin K. Rennels, Friederike Herbst, Stefanie Lesch and David B. Weiner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Nils W. Engel

12 papers receiving 244 citations

Peers

Countries citing papers authored by Nils W. Engel

Since Specialization

Citations

This map shows the geographic impact of Nils W. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils W. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils W. Engel more than expected).

Fields of papers citing papers by Nils W. Engel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils W. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils W. Engel. The network helps show where Nils W. Engel may publish in the future.

Co-authorship network of co-authors of Nils W. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Nils W. Engel. A scholar is included among the top collaborators of Nils W. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils W. Engel. Nils W. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Engineering single-vector logic-gated CAR T cells with transgene sizes beyond current limitations 2026 ·Journal for ImmunoTherapy of Cancer ·Philipp C. Rommel, Nils W. Engel, (unknown), (unknown), (unknown), Donna Gonzales, (unknown), (unknown), (unknown), (unknown), C H June	0
2	Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells 2025 ·Proceedings of the National Academy of Sciences ·Nils W. Engel, Israel Steinfeld, Daniel Ryan, (unknown), Samuel S. Kim, Nils Wellhausen, Linhui Chen, Katherine Wilkins, Daniel Baker, Philipp C. Rommel, Danuta Jarocha, Mercy Gohil, Qian Zhang, Michael C. Milone, Joseph A. Fraietta, Megan M. Davis, Regina M. Young, Carl H. June	5
3	Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors 2025 ·Nature Cancer ·Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, (unknown), (unknown), Nils W. Engel, Neil C. Sheppard, Fan Yi, Ravi Radhakrishnan, Xiaowei Xu, Leyuan Ma, Serge Y. Fuchs, Carl H. June, Wei Guo	3
4	Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors 2024 ·Cancer Immunology Research ·(unknown), Nils Wellhausen, Nils W. Engel, (unknown), (unknown), January Salas-McKee, Adham S. Bear, (unknown), Sangya Agarwal, Julie K. Jadlowsky, Gerald P. Linette, Saar Gill, Carl H. June, Joseph A. Fraietta, Nathan Singh	2
5	Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation 2024 ·Nature Communications ·(unknown), (unknown), Oscar A. Aguilar, Oz Pomp, Omar Johnson, Amanda Finck, Nils W. Engel, Linhui Chen, Nicolas Plachta, John Scholler, Lewis L. Lanier, Carl H. June, Neil C. Sheppard	19
6	Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy 2023 ·Science Translational Medicine ·Nils Wellhausen, Ryan P. O’Connell, Stefanie Lesch, Nils W. Engel, Austin K. Rennels, Donna Gonzales, Friederike Herbst, Regina M. Young, K. Christopher García, David B. Weiner, Carl H. June, Saar Gill	75
7	Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations 2023 ·European Radiology ·(unknown), Christina C. Rolling, Christoph Seidel, Jennifer Erley, Isabel Molwitz, Kai Muellerleile, (unknown), (unknown), (unknown), Nils W. Engel, Carsten Bokemeyer, Gerhard Adam, Enver Tahir, Hang Chen	5
8	Next-Generation CAR T-cell Therapies 2022 ·Cancer Discovery ·Regina M. Young, Nils W. Engel, Uğur Uslu, Nils Wellhausen, Carl H. June	113
9	Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients 2022 ·Bone Marrow Transplantation ·(unknown), Nils W. Engel, Winfried Alsdorf, Christoph Oing, Christian Frenzel, (unknown), Carsten Bokemeyer, Christoph Seidel	1
10	Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow 2020 ·Annals of Hematology ·Nils W. Engel, (unknown), (unknown), Victoria Panagiota, Razif Gabdoulline, Felicitas Thol, Michael Heuser, Walter Fiedler	9
11	Successful Treatment of Delayed Methotrexate Clearance Using Glucarpidase Dosed on Ideal Body Weight in Obese Patients 2020 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Nils W. Engel, (unknown), Winfried Alsdorf, Walter Fiedler, Judith Dierlamm, Carsten Bokemeyer, Claudia Langebrake	2
12	Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia 2019 ·Frontiers in Oncology ·Nils W. Engel, Simon Schliffke, Ulrich Schüller, Christian Frenzel, Carsten Bokemeyer, Christian Kubisch, Davor Lessel	8
13	Canonical Wnt Signaling Drives Tumor-Like Lesions from Sox2-Positive Precursors of the Murine Olfactory Epithelium 2016 ·PLoS ONE ·Nils W. Engel, Julia E. Neumann, Julia Ahlfeld, Annika K. Wefers, (unknown), (unknown), Ulrich Schüller	5
14	Unexpected Success of Watch and Wait Strategy in a Ponatinib-Intolerant Patient With Chronic Myeloid Leukemia 2016 ·Journal of Oncology Practice ·Nils W. Engel, André Constantin, (unknown), Sarit Assouline	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact